Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3735035016 | Product containing only pyrimethamine and sulfadoxine (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3735036015 | Pyrimethamine and sulfadoxine only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only pyrimethamine and sulfadoxine (medicinal product) | Is a | Medicinal product (product) | true | Inferred relationship | Some | ||
| Product containing only pyrimethamine and sulfadoxine (medicinal product) | Has active ingredient | Pyrimethamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only pyrimethamine and sulfadoxine (medicinal product) | Has active ingredient | Sulfadoxine | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet | Is a | True | Product containing only pyrimethamine and sulfadoxine (medicinal product) | Inferred relationship | Some | |
| Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Is a | True | Product containing only pyrimethamine and sulfadoxine (medicinal product) | Inferred relationship | Some |
Reference Sets
FHIR